Cargando…

A40 GUT MICROBIOTA PROMOTES NUTRIENT AVAILABLITY AND PATHOGENESIS OF AN ATTACHING/ EFFACING BACTERIAL PATHOGEN

BACKGROUND: Our gut microbiota plays an important role in protecting the gastrointestinal (GI) tract from invading enteric pathogens. Much of this colonization resistance is mediated by limiting nutrient availability, however, enteric pathogens have evolved strategies to subvert this competition, ut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Q, Allaire, J, Celiberto, L, Yu, H, Vallance, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Poster of Distinction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991097/ http://dx.doi.org/10.1093/jcag/gwac036.040

Ejemplares similares

A9 SIALIC ACID METABOLISM PLAYS A KEY ROLE IN INTESTINAL FITNESS AND VIRULENCE OF AN ATTACHING/ EFFACING BACTERIAL PATHOGEN
por: Liang, Q, et al.
Publicado: (2022)

A199 UTILIZATION OF MUCUS-DERIVED O-GLYCAN SUGARS BY THE PATHOGEN C. RODENTIUM FACILITATE ITS COLONIZATION OF THE MURINE GUT
por: Mslati, M, et al.
Publicado: (2022)

Subversion of actin dynamics by EspM effectors of attaching and effacing bacterial pathogens
por: Arbeloa, Ana, et al.
Publicado: (2008)

Ribosomal Protein S3: A Multifunctional Target of Attaching/Effacing Bacterial Pathogens
por: Gao, Xiaofei, et al.
Publicado: (2011)

Type Three Secretion System in Attaching and Effacing Pathogens
por: Gaytán, Meztlli O., et al.
Publicado: (2016)

Attaching-effacing Bacteria in Animals
por: Wales, A.D., et al.
Publicado: (2005)

A48 LYOPHILIZED FECAL MICROBIOTA TRANSPLANT (FMT) DELAYS THE ONSET OF SPONTANEOUS COLITIS IN MUC2-/- MICE
por: Chan, J J, et al.
Publicado: (2023)

A46 BIOGEOGRAPHIC VARIATION AND FUNCTIONAL PATHWAYS OF THE GUT MICROBIOTA IN CELIAC DISEASE
por: Libertucci, J, et al.
Publicado: (2022)

A51 ROLE OF GUT MICROBIOTA IN THE EPISODIC NATURE OF SYMPTOMS IN IRRITABLE BOWEL SYNDROME
por: Mohan, V, et al.
Publicado: (2022)

Lambda Red-mediated Recombineering in the Attaching and Effacing Pathogen Escherichia albertii
por: Egan, Marisa, et al.
Publicado: (2016)

A47 THE GUT MICROBIOTA INFLUENCES COLONIC HEALING AFTER SURGERY IN PATIENTS UNDERGOING BOWEL RESECTION FOR COLORECTAL CANCER
por: Hajjar, R, et al.
Publicado: (2023)

Attaching-effacing Escherichia coli Infections in Cattle
por: Moxley, Rodney A., et al.
Publicado: (2010)

Control freaks—signals and cues governing the regulation of virulence in attaching and effacing pathogens
por: Turner, Natasha C.A., et al.
Publicado: (2019)

Advances and Challenges in Studying Type III Secretion Effectors of Attaching and Effacing Pathogens
por: Slater, Sabrina L., et al.
Publicado: (2020)

Notch2-dependent classical dendritic cells orchestrate intestinal immunity against attaching and effacing bacterial pathogens
por: Satpathy, Ansuman T., et al.
Publicado: (2013)

A238 ALTERED GUT MICROBIOME COMPOSITION AND FUNCTION ARE ASSOCIATED WITH GUT BARRIER DYSFUNCTION IN HEALTHY RELATIVES OF CROHN’S DISEASE PATIENTS
por: Leibovitzh, H, et al.
Publicado: (2022)

A37 FECAL CALPROTECTIN IN A PEDIATRIC, POPULATION-BASED STUDY: UTILITY IN DIAGNOSIS AND INFLAMMATORY BOWEL DISEASE MONITORING
por: Smyth, M, et al.
Publicado: (2023)

A55 INTERLEUKIN-10 ELICITS CYTOPROTECTION VIA MITOCHONDRIAL SIGNAL TRANSDUCER AND ACTIVATORS OF TRANSCRIPTION 3 (MTSTAT3) TO PREVENT BACTERIAL PATHOBIONT EVOKED MITOCHONDRIAL FRAGMENTATION IN GUT EPITHELIA
por: NavaneethaKrishnan, S, et al.
Publicado: (2022)

A247 MEDITATION AND YOGA FOR IRRITABLE BOWEL SYNDROME (MY-IBS): A RANDOMIZED CONTROLLED TRIAL
por: D’Silva, A, et al.
Publicado: (2022)

A230 THE ROLE OF THE MICROBIOTA IN NOCICEPTOR DEVELOPMENT AND PAIN SENSITIVITY
por: Abdullah, N, et al.
Publicado: (2022)

A157 DEFINITIONS OF MEDITERRANEAN DIET INCONSISTENTLY ASSOCIATE WITH MARKERS OF GUT BARRIER FUNCTION OR SUBCLINICAL INFLAMMATION IN A POPULATION-BASED COHORT
por: Neustaeter, A, et al.
Publicado: (2022)

A234 IN VITRO GUT MICROBIOME AND METABOLITE RESPONSES TO RESISTANT STARCH ARE INDIVIDUALIZED
por: Dobranowski, P, et al.
Publicado: (2022)

A51 INTESTINAL MICROBIOTA DETERMINES ARYL HYDROCARBON RECEPTOR ACTIVATION AND SUSCEPTIBILITY TO COLITIS
por: Rondeau, L, et al.
Publicado: (2023)

A231 COLORECTAL CANCER PROVINCIAL SCREENING OPTIMIZATION USING GUT MICROBIOME AS BIOMARKER
por: Laforest-Lapointe, I
Publicado: (2022)

A77 IMPLEMENTATION OF GUT LINK-IBS; RESULTS OF A SEMI-STRUCTURED INTERVIEW OF PRIMARY CARE PROVIDERS
por: Sharma, S, et al.
Publicado: (2022)

A46 ENTEROBACTERIACEAE ENRICHMENT IN THE GUT MICROBIOME OF CRITICALLY ILL PATIENTS PROMOTES IMMUNE DYSFUNCTION AND SUSCEPTIBILITY TO NOSOCOMIAL INFECTIONS
por: Schlechte, J M, et al.
Publicado: (2023)

A32 PHAGE TREATMENT DELAYS ONSET OF CROHN’S-ASSOCIATED E. COLI DRIVEN COLITIS IN MICE COLONIZED WITH A DEFINED MICROBIOTA
por: Jackson, K, et al.
Publicado: (2023)

A45 FIBER-FREE DIET REDUCES BACTEROIDES ABUNDANCE AND PREVENTS MUCUS DEGRADATION IN MICE COLONIZED WITH MICROBIOTA FROM PATIENTS WITH GENERALIZED ANXIETY DISORDER
por: Rabbia, V, et al.
Publicado: (2023)

A52 GUT-INNERVATING TRPV1+ NEURONS DRIVE CHRONIC VISCERAL PAIN VIA MICROGLIAL P2Y12 RECEPTOR
por: Defaye, M, et al.
Publicado: (2022)

A23 INTESTINAL STEM CELL REGULATION BY THE BACTERIAL METABOLITE ADP-HEPTOSE VIA ACTIVATION OF THE ALPK1-TIFA SIGNALLING PATHWAY
por: Goyal, S, et al.
Publicado: (2023)

A156 MUCOSA-ASSOCIATED MICROBIOTA OF ILEOCOLONIC CROHN’S DISEASE PATIENTS IS DISTINCT FROM COLONIC CROHN’S DISEASE AND ULCERATIVE COLITIS PATIENTS INDEPENDENT OF BIOPSY SITE, ENDOSCOPIC INFLAMMATION AND HOST GENETICS
por: Hernandez-Rocha, C, et al.
Publicado: (2022)

Attaching-and-Effacing Pathogens Exploit Junction Regulatory Activities of N-WASP and SNX9 to Disrupt the Intestinal Barrier
por: Garber, John J., et al.
Publicado: (2017)

A63 THE COLONIC PATHOGEN, ENTAMOEBA HISTOLYTICA ACTIVATES CASPASE-4 IN HUMAN MACROPHAGES THAT CLEAVES GASDERMIN D TO FACILITATE IL-1β SECRETION IN THE ABSENCE OF CELL DEATH
por: Wang, S, et al.
Publicado: (2022)

A185 DUAL BIOLOGIC THERAPY IN A PATIENT WITH NIEMANN-PICK TYPE C AND CROHN DISEASE: A CASE REPORT AND LITERATURE REVIEW
por: Hudson, A, et al.
Publicado: (2022)

The L-Arginine Transporter Solute Carrier Family 7 Member 2 Mediates the Immunopathogenesis of Attaching and Effacing Bacteria
por: Singh, Kshipra, et al.
Publicado: (2016)

Characterization of attaching and effacing Escherichia coli (AEEC) isolated from pigs and sheep
por: Fröhlicher, Erik, et al.
Publicado: (2008)

Human Milk Secretory Antibodies against Attaching and Effacing Escherichia coli Antigens
por: Noguera-Obenza, Marita, et al.
Publicado: (2003)

A172 PSYCHOSOCIAL VARIABLES RELATED TO J-POUCH SURGERY FOR INFLAMMATORY BOWEL DISEASE: A SCOPING REVIEW
por: Hanna, Q, et al.
Publicado: (2022)

Bacterial effector NleL promotes enterohemorrhagic E. coli-induced attaching and effacing lesions by ubiquitylating and inactivating JNK
por: Sheng, Xiangpeng, et al.
Publicado: (2017)

A53 A NOVEL PH-SENSITIVE OPIOID ANALOGUE PROVIDES SUSTAINED ANALGESIA DURING COLONIC INFLAMMATION AND LACKS COMMON SIDE EFFECTS
por: Degro, C E, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j9ol65pbeth1dnbnrj59fft86o